| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T303 |
60-131 |
Sentence |
denotes |
10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): |
| T304 |
132-255 |
Sentence |
denotes |
2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: >1–2 weeks/13.0 (5.7), group 4: >2–3 weeks/12.1 (5.9). |
| T305 |
256-259 |
Sentence |
denotes |
CT: |
| T306 |
260-264 |
Sentence |
denotes |
ALL: |
| T307 |
265-287 |
Sentence |
denotes |
bilateral abnormality: |
| T308 |
288-345 |
Sentence |
denotes |
64 [79%], peripheral 44 [54%], Ill‐defined 66 [81%], GGO: |
| T309 |
346-395 |
Sentence |
denotes |
53 [65%], mainly involving the right lower lobes: |
| T310 |
396-413 |
Sentence |
denotes |
225 [27%] of 849. |
| T311 |
414-441 |
Sentence |
denotes |
Group 1 (n=15): unilateral: |
| T312 |
442-473 |
Sentence |
denotes |
9 [60%]/multifocal 8 [53%]/GGO: |
| T313 |
474-626 |
Sentence |
denotes |
14 [93%]; Group 2 (n = 21): bilateral 19 [90%]/diffuse 11 [52%]/GGO predominance 17 [81%]; Group 3 (n = 30): GGO 17 [57%], consolidation/mixed patterns: |
| T314 |
627-682 |
Sentence |
denotes |
12 [40%]; Group 4 (n=15): consolidation/mixed patterns: |
| T315 |
683-691 |
Sentence |
denotes |
8 [53%]. |
| T316 |
692-698 |
Sentence |
denotes |
Blood: |
| T317 |
699-706 |
Sentence |
denotes |
Group1: |
